KAERVAX PHASE 2 · CANONICAL DOMAIN · 18 SEP 2026

KAERVAX-owned business truth

Explicit rules before execution.

Phase 2 menetapkan domain vendor-neutral yang kecil dan dapat diuji: identitas canonical, lifecycle eksplisit, command boundary, invariant, serta audit semantics—tanpa database, payment gateway, connector runtime, atau autonomous action.

G2 — PASS

G0 — PARTIAL / BLOCKED

Phase 2 scope

SPRINT 2.1Domain Model

Dua belas target concept dimodelkan dengan KAERVAX ownership, canonical ID, relationship, provenance, evidence class, dan batas mutasi.

SPRINT 2.2Lifecycle Rules

Valid transition bersifat eksplisit; invalid transition, approval bypass, unverified payment, dan premature connector execution ditolak.

SPRINT 2.3Commands + Audit

Pure domain commands menghasilkan immutable record dan audit event tanpa menjalankan external side effect atau menyimpan secret.

Evidence boundary

Canonical-domain readiness bukan commercial validation.

G2 PASS hanya membuktikan domain model, lifecycle, commands, invariants, dan audit semantics telah diverifikasi. Belum ada buyer interaction, payment, delivery, atau customer acceptance. G0 tetap PARTIAL / BLOCKED. Phase 3 tidak otomatis diizinkan.

Health signal · GitHub repository